United States · FDA National Drug Code directory
Lorazepam
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65219-368_462a13da-259a-40e7-bd5b-f7f42ae025b7
- Product NDC
- 65219-368
- Form
- INJECTION
- Composition / generic term
- Lorazepam
- Labeler
- Fresenius Kabi USA, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20241213
- Source listing expiry
- 20271231
Source-listed ingredients
- LORAZEPAM — 2 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 25 VIAL in 1 TRAY (65219-368-24) / 1 mL in 1 VIAL (65219-368-14) · 65219-368-24
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →